NDC 0088-2502
Apidra SoloStar
Insulin Glulisine
Apidra SoloStar is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Sanofi-aventis U.s. Llc. The primary component is Insulin Glulisine.
Product ID | 0088-2502_286b7639-8fe3-4fbd-928f-a4fde7746f43 |
NDC | 0088-2502 |
Product Type | Human Prescription Drug |
Proprietary Name | Apidra SoloStar |
Generic Name | Insulin Glulisine |
Dosage Form | Injection, Solution |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2009-02-24 |
Marketing Category | BLA / NDA |
Application Number | BLA021629 |
Labeler Name | sanofi-aventis U.S. LLC |
Substance Name | INSULIN GLULISINE |
Active Ingredient Strength | 100 [iU]/mL |
Pharm Classes | Insulin [Chemical/Ingredient],Insulin Analog [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |